Physician profile
Gia E Johnson
NPI 1063521110
$296.67
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $176 · 2020: $30.90 · 2022: $89.40.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $89.40 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $85.54 | 2019-2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $45.91 | 2019 | |
| Alkermes, INC. | $18.43 | 2019 | |
| Neurocrine Biosciences, INC. | $18.20 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $16.85 | 2020 | |
| Vanda Pharmaceuticals INC. | $11.26 | 2019 | |
| Janssen Pharmaceuticals, INC | $11.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gia Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.